These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7054685)

  • 1. Treatment of venous thrombosis with subcutaneous heparin.
    Salzman EW
    N Engl J Med; 1982 Jan; 306(4):232-4. PubMed ID: 7054685
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
    N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous or intravenous heparin for deep vein thrombosis.
    Bounameaux H; Krahenbuhl B
    Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1690-1. PubMed ID: 3113593
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin treatment. Comparison between intravenous and subcutaneous administration].
    Krähenbühl B; Simon CA; Bouvier CA; Schinas P; Hopf MA; Cochet B
    Schweiz Med Wochenschr; 1979 Sep; 109(36):1322-5. PubMed ID: 504973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
    N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous heparin for venous thrombosis.
    N Engl J Med; 1982 Jul; 307(1):56-8. PubMed ID: 7078626
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
    Teo CP; Lim HL; Kueh YK
    Thromb Haemost; 1994 Aug; 72(2):328-9. PubMed ID: 7831676
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous compared with intravenous heparin for deep vein thrombosis.
    Burnum JF
    Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of deep venous thrombosis with fixed doses of subcutaneous heparin. Preliminary results].
    Lastória S; Maffei FH; Rollo HA; Yoshida WB; Castiglia V; Lorenzi LC; Lintz JA; Sanchez MA
    AMB Rev Assoc Med Bras; 1983; 29(11-12):188-90. PubMed ID: 6608754
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous compared with intravenous heparin for deep vein thrombosis.
    Young MA
    Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616226
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
    Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg JY; Hantute N; Thuillez C; Courtois H
    Therapie; 1994; 49(2):101-5. PubMed ID: 7817331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems of deep venous thrombosis during pregnancy.
    Pfeifer GW; von Nathusius U
    Acta Univ Carol Med Monogr; 1972; 52():193-4. PubMed ID: 4669822
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems of heparin therapy].
    Makatsariia AD; Smolianitskiĭ AIa
    Klin Med (Mosk); 1980 Oct; 58(10):18-21. PubMed ID: 7003239
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs.
    Scolding N
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1551-2. PubMed ID: 3111633
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study.
    Robinson AM; McLean KA; Greaves M; Channer KS
    Postgrad Med J; 1993 Feb; 69(808):115-6. PubMed ID: 8506190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.